“It doesn’t matter if you’re working as a nurse, or a medical assistant, or in food services. Living in certain areas of the city increases your risk.”
Hyacinth EmpinadoThis story was a punch in the gut. Deus reminds me a lot of my mom. They're both immigrants, hospital workers, particular about disinfecting every surface, and just trying to "keep up in America." Beautifully written story by @EricBoodman.
bit.ly/2CMqcev via @statnews
in this episode, we dig into Biogen's much-dissected data on a treatment for Alzheimer's disease and STAT's Eric Boodman spins a drug-discovery yarn.
Hyacinth EmpinadoICYMI @RebeccaDRobbins went to CTAD and asked experts what they think about Biogen's Alzheimer’s reveal. Plus learn how one-eyed sheep led to a treatment for a rare cancer from @ericboodman in the latest #ReadoutLOUD podcast.
In this episode, STAT's Ed Silverman joins us to explain the ongoing controversy over a drug meant to prevent premature births that might not actually work.
Hyacinth EmpinadoOn this week's #ReadoutLOUD podcast:
📌 @pharmalot breaks down a drug controversy
📌this year's HLTH conference
📌@levfacher talks about the debate on new drugs in Congress
+ I make my first podcast cameo
Participating in an Alzheimer's trial "was being part of something bigger," said one patient, and losing that "hurt in some ways more than anything else.”
Hyacinth Empinado“I had this overwhelming sense of dread, almost like a hopelessness.” @DrewQJoseph writes about how patients in Biogen's failed Alzheimer's trial reacted to the news. Video by me.